Skip to main content

Table 1 Diagnostic findings

From: Evaluation of suspected malignant hyperthermia events during anesthesia

No Age/sex IVCT Year of incidence Surgery Prev. Anesth. Genetic status CGS Histopathology
1 46 ♂ MHS 2010 Liposuction 1 Negative 48 WPF
2 58 ♂ MHS 2010 Spongiosaplasty 2 Gly4037Alafs 38 WPF
3 36 ♂ MHS 2010 Urachal fistula - Negative 43 WPF
4 14 ♂ MHS 2009 Lower leg fracture - Glu2174Ala 53 WPF
5 18 ♂ MHS 2008 Gunshot injury - Val4234Leu 53 WPF
6 45 ♂ MHS 2007 Hemilaminectomy - Negative 38 WPF
7 10 ♂ MHS 1995 Appendectomies - Negative 40 WPF
8 62 ♀ MHEh 2009 Bursectomy - Negative 15 WPF
9 32 ♀ MHEh 2009 Caesarean section - Negative 40 Myopathy
10 29 ♀ MHEh 2006 Uterine abrasion - Negative 15 WPF
11 3 ♂ MHEh 1992 Tonsillectomy - Negative 18 WPF
12 35 ♀ MHN 2011 Uterine abrasion 2 Negative 18 WPF
13 54 ♂ MHN 2010 Aortocoronary bypass - Negative 30 WPF
14 46 ♀ MHN 2009 Uterine abrasion 1 Negative 30 WPF
15 34 ♀ MHN 2008 Colon resection - Negative 25 WPF
16 57 ♀ MHN 2007 Inguinal hernia - Negative 30 WPF
17 21 ♀ MHN 2007 Mandible fracture - Negative 0 WPF
18 39 ♂ MHN 2006 Appendectomies - Negative 30 WPF
19 3 ♂ MHN 1998 Orchidopexy - Negative 30 WPF
  1. Age Patients’ age MH-suspected episode occurred, IVCT In vitro contracture test, ♂ Male, ♀ Female, MHS Malignant hyperthermia susceptible, MHN Malignant hyperthermia non-susceptible, MHEh Malignant hyperthermia equivocal to halothane, WPF Without pathological finding.